A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing
Here, the authors engineer an attenuated knock-out Leishmania (LmCen −/−) vaccine that is safe in immunocompromised mice and induces an immune response and protection similar to leishmanization with wild-type Leishmania. Since LmCen −/− is antibiotic resistant marker free, it is a candidate for clin...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a50605a064c049859dfcd1fb76a10dad |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|